L059-0513 Screening compound: 1-{[4-(morpholine-4-carbonyl)phenyl]methyl}-4-(prop-2-en-1-yl)-1,2,3,4-tetrahydroquinoxaline-2,3-dione

L059-0513 Screening compound: 1-{[4-(morpholine-4-carbonyl)phenyl]methyl}-4-(prop-2-en-1-yl)-1,2,3,4-tetrahydroquinoxaline-2,3-dione
L059-0513 Screening compound: 1-{[4-(morpholine-4-carbonyl)phenyl]methyl}-4-(prop-2-en-1-yl)-1,2,3,4-tetrahydroquinoxaline-2,3-dione alternative view

Chemical Structure Depiction of ChemDiv screening compound L059-0513
1-{[4-(morpholine-4-carbonyl)phenyl]methyl}-4-(prop-2-en-1-yl)-1,2,3,4-tetrahydroquinoxaline-2,3-dione

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L059-0513

Molecular Formula

C23H23N3O4 (C23 H23 N3 O4)

Compound Name

1-{[4-(morpholine-4-carbonyl)phenyl]methyl}-4-(prop-2-en-1-yl)-1,2,3,4-tetrahydroquinoxaline-2,3-dione

IUPAC name

1-{[4-(morpholine-4-carbonyl)phenyl]methyl}-4-(prop-2-en-1-yl)-1234-tetrahydroquinoxaline-23-dione

SMILES

C=CCN(c(cccc1)c1N(Cc(cc1)ccc1C(N1CCOCC1)=O)C1=O)C1=O

InChI

InChI=1S/C23H23N3O4/c1-2-11-25-19-5-3-4-6-20(19)26(23(29)22(25)28)16-17-7-9-18(10-8-17)21(27)24-12-14-30-15-13-24/h2-10H,1,11-16H2

InChI Key

QJBQQZGMZVSRGY-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27227629

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

405.45

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

1.829

Distribution Coefficient, logD

1.829

Water Solubility, LogSw

-2.15

Polar Surface Area

55.330

Acid Dissociation Constant (pKa)

26.58

Base Dissociation Constant (pKb)

-4.18

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

26.10

L059-0513 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

PI3K-Targeted Library (17255 compounds)

Targeted Diversity Library (40567 compounds)

Epitranscriptome Focused Small Molecule Library (20952 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Nervous system
  • Hemic and lymphatic
  • Congenital
  • Metabolic
Targets:
  • Kinases
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with L059-0513 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L059-0513?
Check Price and Availability of L059-0513, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L059-0513 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L059-0513
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L059-0513
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L059-0513 available by request